We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+19.58%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$161M
AUM Growth
+$20.9M
(+15%)
Cap. Flow
-$8.51M
Cap. Flow
% of AUM
-5.29%
Top 10 Holdings %
Top 10 Hldgs %
48.45%
Holding
88
New
12
Increased
11
Reduced
19
Closed
14
Top Buys
| 1 |
DexCom
DXCM
|
+$4.07M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
+$3.08M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
+$2.81M |
| 4 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$2.01M |
| 5 |
TVRD
Tvardi Therapeutics
TVRD
|
+$1.31M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$3.22M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
+$2.15M |
| 3 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$1.98M |
| 4 |
CLLS
Cellectis
CLLS
|
+$1.97M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
+$1.77M |
Sector Composition
| 1 | Healthcare | 80.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $24.1M | 14.99% |
262,121
-41,500
| -14% | -$3.22M |
|
2
AtriCure
ATRC
$1.75B
| $8.59M | 5.34% |
384,145
| – | – |
|
|
ONC
3
BeOne Medicines Ltd
ONC
$32.3B
| $7.43M | 4.62% |
71,849
-1,187
| -2% | -$88.5K |
|
|
IMMU
4
DELISTED
Immunomedics Inc
IMMU
| $6.44M | 4% |
460,451
-177,249
| -28% | -$1.77M |
|
|
5
BioCryst Pharmaceuticals
BCRX
$2.39B
| $6.25M | 3.88% |
1,193,228
+602,100
| +102% | +$3.08M |
|
|
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
| $5.96M | 3.7% |
216,119
| – | – |
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
| $5.67M | 3.52% |
116,770
+10,000
| +9% | +$546K |
|
|
BPMC
8
DELISTED
Blueprint Medicines
BPMC
| $5.29M | 3.29% |
76,000
-6,000
| -7% | -$321K |
|
|
ALDR
9
DELISTED
Alder Biopharmaceuticals
ALDR
| $4.24M | 2.63% |
346,013
+125,000
| +57% | +$1.3M |
|
|
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
| $3.51M | 2.18% |
435,000
+415,933
| +2,181% | +$2.81M |
|
11
Neurocrine Biosciences
NBIX
$17.3B
| $3.34M | 2.07% |
54,508
| – | – |
|
|
ACHN
12
DELISTED
Achillion Pharmaceuticals
ACHN
| $3.23M | 2% |
718,272
+451,772
| +170% | +$2.01M |
|
|
LKFT
13
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $3.22M | 2% |
31,609
-7,000
| -18% | -$612K |
|
14
Insulet
PODD
$11B
| $3.17M | 1.97% |
57,484
-6,000
| -9% | -$328K |
|
15
iShares Biotechnology ETF
IBB
$9.24B
| $2.9M | 1.8% |
26,100
| – | – |
|
16
MacroGenics
MGNX
$275M
| $2.85M | 1.77% |
154,200
+35,000
| +29% | +$606K |
|
|
17
DexCom
DXCM
$28.1B
| $2.81M | 1.75% |
+230,000
| New | +$4.07M |
|
18
Akebia Therapeutics
AKBA
$370M
| $2.67M | 1.66% |
135,738
| – | – |
|
19
Ascendis Pharma A/S
ASND
$17.6B
| $2.62M | 1.63% |
72,226
+39,012
| +117% | +$1.12M |
|
20
Voyager Therapeutics
VYGR
$193M
| $2.41M | 1.5% |
117,259
-87,549
| -43% | -$988K |
|
|
RDUS
21
DELISTED
Radius Health, Inc.
RDUS
| $2.06M | 1.28% |
53,309
| – | – |
|
|
DERM
22
DELISTED
Dermira, Inc.
DERM
| $2.04M | 1.27% |
75,500
| – | – |
|
|
ZGNX
23
DELISTED
Zogenix, Inc.
ZGNX
| $1.84M | 1.14% |
52,500
-3,309
| -6% | -$44.9K |
|
24
Ardelyx
ARDX
$1.31B
| $1.82M | 1.13% |
325,409
-48,000
| -13% | -$253K |
|
25
Spyre Therapeutics
SYRE
$8.86B
| $1.72M | 1.07% |
13,984
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML